DYNE-251

· Dyne Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DYNE-251, covering 2025-08-13 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping [Phase 1, Phase 2]

See pricing